We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
The Office of Drug Control (ODC) has issued an infringement notice totalling $19,800 to Queensland-based company Cannatrek Technologies Pty Ltd (Cannatrek) for alleged breaches of its medicinal cannabis licence.
It is alleged that Cannatrek failed to meet its statutory reporting obligations to the ODC under the Narcotic Drugs Act 1967. This requirement ensures cannabis industry participants inform the ODC of changes to ownership, management or functional control of medicinal cannabis operations and production.
Licence holders must understand and comply with their responsibilities under the Act and all licence conditions.
Consequences for non-compliance with relevant laws include not only financial penalties but could also lead to civil or criminal proceedings being brought against those who fail to meet their requirements. Repeated failure to comply may also result in licence suspension or revocation.
If you suspect non-compliance in relation to medicinal cannabis cultivation or manufacture, you can report illegal or questionable practices to the ODC via its online ODC Tip-off form.
Contact for members of the media:
- Email: news@health.gov.au
- Phone: 02 6289 7400